These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 29605863)

  • 1. Increased tenascin C and DKK1 in vitiligo: possible role of fibroblasts in acral and non-acral disease.
    Esmat SM; Hadidi HHE; Hegazy RA; Gawdat HI; Tawdy AM; Fawzy MM; AbdelHalim DM; Sultan OS; Shaker OG
    Arch Dermatol Res; 2018 Jul; 310(5):425-430. PubMed ID: 29605863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Dickkopf1 on the senescence of melanocytes: in vitro study.
    Rani S; Chauhan R; Parsad D; Kumar R
    Arch Dermatol Res; 2018 May; 310(4):343-350. PubMed ID: 29442138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tenascin is overexpressed in vitiligo lesional skin and inhibits melanocyte adhesion.
    Le Poole IC; van den Wijngaard RM; Westerhof W; Das PK
    Br J Dermatol; 1997 Aug; 137(2):171-8. PubMed ID: 9292062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunolocalization of tenascin-C in vitiligo.
    Abdou AG; Maraee AH; Shoeib MA; Elbana R
    Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):501-11. PubMed ID: 22495383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical expression of aberrant Notch-1 signaling in vitiligo: an implication for pathogenesis.
    Seleit I; Bakry OA; Abdou AG; Dawoud NM
    Ann Diagn Pathol; 2014 Jun; 18(3):117-24. PubMed ID: 24560443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expressional changes in the intracellular melanogenesis pathways and their possible role in the pathogenesis of vitiligo.
    Kingo K; Aunin E; Karelson M; Rätsep R; Silm H; Vasar E; Kõks S
    J Dermatol Sci; 2008 Oct; 52(1):39-46. PubMed ID: 18514490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DKK1 is highly expressed in the dermis of vitiligo lesion: is there association between DKK1 and vitiligo?
    Oh SH; Kim JY; Kim MR; Do JE; Shin JY; Hann SK
    J Dermatol Sci; 2012 May; 66(2):163-5. PubMed ID: 22386696
    [No Abstract]   [Full Text] [Related]  

  • 8. Discoidin domain receptor-1 as a player in impairment of melanocytes adhesion process in vitiligo.
    Elgarhy LH; Abdullatif A; Abdelazim R; El-Desouky KI
    G Ital Dermatol Venereol; 2016 Oct; 151(5):473-9. PubMed ID: 26091274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal hydrogen peroxide is not increased in lesional and non-lesional skin of vitiligo.
    Zailaie MZ
    Arch Dermatol Res; 2017 Jan; 309(1):31-42. PubMed ID: 27783153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of abnormal secretion of DKK1 by fibroblasts on melanocytes function in vitiligo.
    Chen J; Zhang L; Li Y; Pan X; Shao X; Liu L; Chen Y; Chen T; Chen J
    J Eur Acad Dermatol Venereol; 2024 Aug; 38(8):e677-e679. PubMed ID: 38404153
    [No Abstract]   [Full Text] [Related]  

  • 11. New insights into the pathogenesis of vitiligo: imbalance of epidermal cytokines at sites of lesions.
    Moretti S; Spallanzani A; Amato L; Hautmann G; Gallerani I; Fabiani M; Fabbri P
    Pigment Cell Res; 2002 Apr; 15(2):87-92. PubMed ID: 11936274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential Expression of Nitric Oxide Synthase Isoforms nNOS and iNOS in Patients with Non-Segmental Generalized Vitiligo.
    Vaccaro M; Irrera N; Cutroneo G; Rizzo G; Vaccaro F; Anastasi GP; Borgia F; Cannavò SP; Altavilla D; Squadrito F
    Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29186858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acral lesions of vitiligo: why are they resistant to photochemotherapy?
    Esmat SM; El-Tawdy AM; Hafez GA; Zeid OA; Abdel Halim DM; Saleh MA; Leheta TM; Elmofty M
    J Eur Acad Dermatol Venereol; 2012 Sep; 26(9):1097-104. PubMed ID: 21851425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression analysis of melanocortin system in vitiligo.
    Kingo K; Aunin E; Karelson M; Philips MA; Rätsep R; Silm H; Vasar E; Soomets U; Kõks S
    J Dermatol Sci; 2007 Nov; 48(2):113-22. PubMed ID: 17651944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Senescence in the lesional fibroblasts of non-segmental vitiligo patients.
    Rani S; Bhardwaj S; Srivastava N; Sharma VL; Parsad D; Kumar R
    Arch Dermatol Res; 2017 Mar; 309(2):123-132. PubMed ID: 28078437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of gene expression levels of proopiomelanocortin (POMC) and melanocortin-1 receptor (MC1R) in vitiligo.
    Nagui NA; Mahmoud SB; Abdel Hay RM; Hassieb MM; Rashed LA
    Australas J Dermatol; 2017 May; 58(2):e36-e39. PubMed ID: 26437741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of granulysin expression in vitiligo and halo-nevus.
    Hlača N; Vičić M; Kaštelan M; Dekanić A; Prpić-Massari L
    Sci Rep; 2024 Jul; 14(1):16580. PubMed ID: 39020008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide profiling reveals pervasive transcriptional alterations in fibroblasts derived from lesional skin in vitiligo including a reduced potential to proliferate.
    Gupta R; Misri R; Gupta A; Chowdhary M; Singh A
    Exp Dermatol; 2023 Apr; 32(4):331-340. PubMed ID: 36333875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptome analysis reveals markers of aberrantly activated innate immunity in vitiligo lesional and non-lesional skin.
    Yu R; Broady R; Huang Y; Wang Y; Yu J; Gao M; Levings M; Wei S; Zhang S; Xu A; Su M; Dutz J; Zhang X; Zhou Y
    PLoS One; 2012; 7(12):e51040. PubMed ID: 23251420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms underlying the dysfunction of melanocytes in vitiligo epidermis: role of SCF/KIT protein interactions and the downstream effector, MITF-M.
    Kitamura R; Tsukamoto K; Harada K; Shimizu A; Shimada S; Kobayashi T; Imokawa G
    J Pathol; 2004 Apr; 202(4):463-75. PubMed ID: 15095274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.